Fig. 4From: Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based studyROC curves for a multivariable model (including LODDS, age, sex, T stage, and radiotherapy), LODDS, and N classification predicting 1-year (A), 3-year (B), 5-year (C), and 10-year (D) OS of patients with NSCLC who received neoadjuvant therapy. ROC, receiver operating characteristic; LODDS, log odds of positive lymph node; OS, overall survival; NSCLC, non-small cell lung cancerBack to article page